Grb14 is an endogenous inhibitor of insulin signaling
Novel Grb14-Mediated Cross Talk between Insulin and p62/Nrf2 Pathways Regulates Liver Lipogenesis and Selective Insulin Resistance.
Specimen part, Treatment